Samirah, - and S. Sjamsiah, - and M. Yogiarto (2017) Continuous infusion versus intermittent bolus furosemide in heart failure NYHA III-IV. In: Proceeding The 17th Asian Conference on Clinical Pharmacy (ACCP), 2017, Yogyakarta.

	Text (FULLTEXT) Bukti C-17 Artikel.pdf Download (10MB)
	Text (KUALITAS KARIL) Bukti C-17 Kualitas Karil.pdf Download (232kB)
	Text (SIMILARITY) Bukti C-17 Turnitin.pdf Download (988kB)

Abstract

The study was designed to investigate the therapeutic effect of Continuous Infusion (CI) and Intermittent Bolus (IB) administration of furosemide on patients with NYHA class III-IV heart failure hospitalized in Dr. Soetomo Hospital Surabaya. Thirteen patients received CI of furosemide and 10 patients received IB furosemide. Total urine output, net urine output (nUO/24 h) and urinary sodium excretion were monitored over 24 h. nUO/24 h of IB and CI were 1292 ± 299 mL and 2081 ± 637 mL, respectively. CI group showed significantly higher total urinary output than IB group (3399 ± 793 mL/ 24 h vs. 2556 ± 343 mL/24 h). The urinary sodium excretion of CI and IB were 302 ± 73 mmol/24 h and 228 ± 58 mmol/24 h, respectively. CI of furosemide resulted in higher total urinary output, net urinary output and urinary sodium excretion than IB furosemide in patients with NYHA class III and IV heart failure.

Actions (login required)

View Item